Evidence map›Paper›PMID 37291166›Full record

ArticleScientific reports2023

Investigating the novel-binding site of RPA2 on Menin and predicting the effect of point mutation of Menin through protein-protein interactions.

Gurjeet Kaur, Manisha Prajapat, Harvinder Singh, Phulen Sarma, Sanjay Kumar Bhadada, Nishant Shekhar, Saurabh Sharma, Shweta Sinha, Subodh Kumar, Ajay Prakash and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Gurjeet KaurDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Manisha Prajapat *Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Harvinder Singh *Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Phulen SarmaDepartment of Pharmacology, AIIMS, Guwahati, India.
Sanjay Kumar BhadadaDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Nishant ShekharDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Saurabh SharmaDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Shweta SinhaDepartment of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, India.
Subodh KumarDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Ajay PrakashDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India.
Bikash MedhiDepartment of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Research Block B, 4th Floor, Lab No 4044, Chandigarh, 160012, India. drbikashus@yahoo.com.ORCID 0000-0002-4017-641X
Post Graduate Institute of Medical Education and Research · INAll India Institute of Medical Sciences Raipur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-protein interactions (PPIs) play a critical role in all biological processes. Menin is tumor suppressor protein, mutated in multiple endocrine neoplasia type 1 syndrome and has been shown to interact with multiple transcription factors including (RPA2) subunit of replication protein A (RPA). RPA2, heterotrimeric protein required for DNA repair, recombination and replication. However, it's still remains unclear the specific amino acid residues that have been involved in Menin-RPA2 interaction. Thus, accurately predicting the specific amino acid involved in interaction and effects of MEN1 mutations on biological systems is of great interests. The experimental approaches for identifying amino acids in menin-RPA2 interactions are expensive, time-consuming, and challenging. This study leverages computational tools, free energy decomposition and configurational entropy scheme to annotate the menin-RPA2 interaction and effect on menin point mutation, thereby proposing a viable model of menin-RPA2 interaction. The menin-RPA2 interaction pattern was calculated on the basis of different 3D structures of menin and RPA2 complexes, constructed using homology modeling and docking strategy, generating three best-fit models: Model 8 (- 74.89 kJ/mol), Model 28 (- 92.04 kJ/mol) and Model 9 (- 100.4 kJ/mol). The molecular dynamic (MD) was performed for 200 ns and binding free energies and energy decomposition analysis were calculated using Molecular Mechanics Poisson-Boltzmann Surface Area (MM/PBSA) in GROMACS. From binding free energy change, model 8 of Menin-RPA2 exhibited most negative binding energy of - 205.624 kJ/mol, followed by model 28 of Menin-RPA2 with - 177.382 kJ/mol. After S606F point mutation in Menin, increase of BFE (ΔG

Indexed as

Multiple Endocrine Neoplasia Type 1Point MutationAmino AcidsBinding SitesHumansMutationReplication Protein ATranscription FactorsAmino AcidsReplication Protein ARPA2 protein, humanTranscription Factors

Identifiers

PMID37291166
PMCPMC10250348
OpenAlexW4379966590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.